期刊
CLINICAL CHEMISTRY AND LABORATORY MEDICINE
卷 56, 期 5, 页码 838-842出版社
WALTER DE GRUYTER GMBH
DOI: 10.1515/cclm-2017-0644
关键词
electrochemiluminescence immunoassay (ECLIA); hyperprolactinemia; pregnancy; prolactin (PRL); reference intervals (RIs)
资金
- Science and Technology Department of Hunan Province [2013FJ4087]
Background: Reference intervals (RIs) play key roles in clinical diagnosis, treatment and prognosis. However, RIs for clinical testing tend to be confined to the general population, and RIs for pregnant women are not very comprehensive. In this study, we establish RIs for prolactin (PRL) in healthy pregnant and postpartum women in the Chinese population. Methods: Healthy pregnant women (n = 378) were divided into groups according to whether they were in the first, second or third trimester of pregnancy. Healthy postpartum women (n = 493) were separated into four groups according to mode of delivery as follows: postvaginal (24 and 48 h) or postcesarean (24 and 48 h). Healthy, non-pregnant women (n = 123) were enrolled as a control group. Serum PRL levels were measured by electrochemiluminescence immunoassay, and RIs were established for each group. Results: The RIs for PRL were as follows: healthy non-pregnant women, 178.89-757.52 mu IU/mL; first trimester, 621.20-3584.00 mu IU/mL; second trimester, 1432.00-5349.68 mu IU/mL; third trimester, 4087.33-9733.65 mu IU/mL; 24 and 48 h postvaginal delivery (combined), 7865.36-10998.86 mu IU/mL; and 24 and 48 h postcesarean delivery, 4556.41-7675.99 and 6578.45-9980.45 mu IU/mL, respectively. Conclusions: PRL RIs for pregnant women were established according to trimester, days postpartum and mode of delivery, thus providing a clinical reference for medical staff.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据